Sundaram Multi Pap Falls to 52-Week Low of Rs.1.61 Amid Continued Downtrend

Recent Price Movement and Market Context

On 25 Nov 2025, Sundaram Multi Pap's share price touched Rs.1.61, the lowest level recorded in the past year. The stock has experienced a consecutive five-day decline, resulting in a cumulative return of -6.81% during this period. Today's performance showed a day change of -1.65%, underperforming its sector by approximately -1.96%. This contrasts with the broader market trend, where the Sensex opened 108.22 points higher and was trading at 85,040.91, a 0.17% gain, edging closer to its 52-week high of 85,801.70.

While the Sensex and BSE Small Cap indices showed positive momentum, Sundaram Multi Pap's share price remained below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning indicates sustained weakness relative to short- and long-term price trends.

Long-Term Performance and Comparative Analysis

Over the last twelve months, Sundaram Multi Pap's stock has recorded a return of -30.89%, significantly lagging behind the Sensex, which posted a positive return of 6.17% over the same period. The stock's 52-week high was Rs.2.97, highlighting the extent of the decline from its peak. This underperformance extends beyond the past year, with the stock trailing the BSE500 benchmark in each of the last three annual periods.

Financial Metrics and Operational Highlights

The company’s long-term financial indicators reveal modest growth and constrained profitability. The average Return on Capital Employed (ROCE) stands at 1.94%, reflecting limited efficiency in generating returns from capital investments. Operating profit has shown an annual growth rate of 2.88% over the past five years, indicating slow expansion in core earnings.

Debt servicing capacity remains a concern, with the average EBIT to Interest ratio at 0.16, suggesting limited earnings available to cover interest expenses. This ratio points to a cautious stance on the company’s ability to manage its financial obligations comfortably.

Profitability and Risk Considerations

Sundaram Multi Pap’s profitability has faced notable pressure, with operating profits declining by 137.1% over the past year. This negative trend in earnings contributes to the stock’s classification as relatively risky when compared to its historical valuation averages. The stock’s risk profile is further underscored by its consistent underperformance against broader market indices.

Despite these challenges, the company reported positive quarterly results in September 2025. The Profit Before Depreciation, Interest and Taxes (PBDIT) reached Rs.1.74 crore, the highest quarterly figure recorded. Operating profit to net sales ratio also peaked at 6.68%, while Profit Before Tax excluding other income stood at Rs.0.79 crore, marking the best quarterly performance in recent periods.

Shareholding Pattern and Market Position

The majority of Sundaram Multi Pap’s shares are held by non-institutional investors, indicating a shareholder base dominated by retail or individual investors rather than large financial institutions. The company operates within the miscellaneous industry and sector, which often encompasses diverse business activities and can be subject to varied market dynamics.

Contextualising Sundaram Multi Pap’s Market Performance

The stock’s recent decline to Rs.1.61 reflects a continuation of a downward trend that has persisted over several months. While the broader market indices, including the Sensex and BSE Small Cap, have shown resilience and positive returns, Sundaram Multi Pap’s performance has diverged notably. This divergence is evident in the stock’s position below all major moving averages, signalling a lack of upward momentum in price action.

Investors and market participants observing the stock will note the contrast between the company’s quarterly operational improvements and the overall negative trajectory in share price and profitability metrics. The quarterly highs in PBDIT and operating profit to net sales ratio suggest pockets of operational strength, albeit within a broader context of subdued financial performance.

Summary of Key Price and Performance Indicators

The stock’s 52-week low of Rs.1.61 represents a significant milestone in its price history, down from a 52-week high of Rs.2.97. The five-day consecutive decline and underperformance relative to the sector highlight ongoing challenges in regaining positive momentum. The one-year return of -30.89% contrasts sharply with the Sensex’s 6.17% gain, underscoring the stock’s relative weakness.

Financial ratios such as ROCE at 1.94% and EBIT to Interest ratio at 0.16 provide insight into the company’s operational and financial constraints. Meanwhile, quarterly results from September 2025 offer some evidence of improved earnings capacity, though these have yet to translate into sustained share price recovery.

Conclusion

Sundaram Multi Pap’s fall to a 52-week low of Rs.1.61 marks a notable point in its recent market journey. The stock’s performance over the past year and recent days reflects a combination of subdued financial metrics and market pressures. While quarterly operational figures show some positive developments, the overall trend remains subdued relative to broader market indices and sector peers.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →